Current Psychopharmacology
Volume 8, 3 Issues, 2019
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
ISSN: 2211-5579 (Online)
ISSN: 2211-5560 (Print)
This journal supports open access
Aims & Scope
Current Psychopharmacology publishes peer-reviewed expert full-length/mini reviews, original research articles and single topic guest edited issues on all aspects of pre-clinical and clinical research in psychopharmacology. The journal aims to be the leading forum for expert review articles in the field. The journal also accepts high-level original research articles on outstanding topics of preclinical and clinical psychopharmacology.
Current Psychopharmacology
,Volume 8
-Number 1
Biography Open Access
Meet Our Editorial Board Member
Preface
Review Article Open Access
The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
, 8(1): 5 - 26Murray Johns*
DOI: 10.2174/2211556007666180503170231
The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
Review Article
Protein Chimera-based Ca2+ Rewiring as a Treatment Modality for Neurodegeneration
, 8(1): 27 - 40Netra Unni Rajesh and Anam Qudrat*
DOI: 10.2174/2211556007666181001102702
Protein Chimera-based Ca2+ Rewiring as a Treatment Modality for Neurodegeneration
Review Article
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
, 8(1): 41 - 54Andreea L. Seritan*, Peter Ureste, Tammy Duong and Jill L. Ostrem
DOI: 10.2174/2211556007666180328142953
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
Research Article Open Access
Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
, 8(1): 55 - 63Muhammad Akmal Yazdani, Muhammad Jamir Anwar, Bushra Parveen and Divya Vohora*
DOI: 10.2174/2211556007666180705130103
Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
Research Article
Substance Use Disorder Related to Kratom (Mitragyna speciosa) Use in Malaysia
, 8(1): 64 - 71Darshan Singh, Mohammad F.I.L. Abdullah, Balasingam K. Vicknasingam and Christian P. Müller*
DOI: 10.2174/2405461503666180420120649
Substance Use Disorder Related to Kratom (Mitragyna speciosa) Use in Malaysia
Research Article
Systemic Injections of Primidone Cause Wake-Inducing Effects in Rats
, 8(1): 72 - 78Mireille Salas-Crisóstomo, María J. Franco-Tormo, Niurka Trujillo-Paredes, Gloria Arankowsky-Sandoval, Óscar Arias-Carrión, Sérgio Machado and Eric Murillo-Rodríguez*
DOI: 10.2174/2211556007666180425143506
Systemic Injections of Primidone Cause Wake-Inducing Effects in Rats
Articles Ahead of Print
Sertraline Associated with REM Sleep Behavior Disorder: A Case Report
Seyed Mostafa Mansouripour * and Dharmendra Kumar
DOI: 10.2174/2211556008666190802101939
View Abstract
Neurosteroids and Affective Disorders in Women
Rodrigo Guiza Zayas *, Mónica Flores Ramos , Norma Bernal Santamaría , María Fernanda Del-Pino Mijares and Marián Serna-García
DOI: 10.2174/2211556008666190724113554
View Abstract
Systematic Review of Local Studies Regarding Efficiency of Add-On Medications on Negative Symptoms of Schizophrenia: A Meta-Analysis
Saeed Shoja Shafti*
DOI: 10.2174/2211556008666190405143828
View Abstract
Evaluation of Second Generation Antipsychotics, as Augmentative Plan, in Treatment-Resistant Obsessive-Compulsive Disorder
Saeed Shoja Shafti* and Hamid Kaviani
DOI: 10.2174/2211556008666190314113446
View Abstract
Low-Dose Lithium for Long-Term Treatment of Clozapine- Induced Neutropenia: A Case Series
Muhammad R. Baig*
DOI: 10.2174/2211556008666190130165540
View Abstract
Oral Monosodium Glutamate Differentially Affects Open-Field Behaviours, Behavioural Despair and Place Preference in Male and Female Mice
Onaolapo AY, Olawore OI, Yusuf FO, Adeyemo AM, Adewole IO and Onaolapo OJ*
DOI: 10.2174/2211556008666181213160527
View Abstract
A Pilot Study of Plasma Antipsychotic Drugs Concentrations of First Episode Patients with Psychosis From Epirus - Greece
Vassiliki A. Boumba*, Petros Petrikis, Lisbeth Patteet, Maria Baou , Georgios Rallis, Apostolos Metsios, Andreas Karambas, Kristof Maudens and Venetsanos Mavreas
DOI: 10.2174/1573412914666180611110805
View Abstract
Abstracts Ahead of Print
There are currently no Abstracts Ahead of Print available for this journal.
Published Contents
- Current Psychopharmacology, Volume 8, 2019
- Current Psychopharmacology, Volume 7, 2018
- Current Psychopharmacology, Volume 6, 2017
- Current Psychopharmacology, Volume 5, 2016
- Current Psychopharmacology, Volume 4, 2015
- Current Psychopharmacology, Volume 3, 2014
- Current Psychopharmacology, Volume 2, 2013
- Current Psychopharmacology, Volume 1, 2012
Editor's Choice
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
, 2019; 8(1): 41 - 54Andreea L. Seritan*, Peter Ureste, Tammy Duong and Jill L. Ostrem
DOI: 10.2174/2211556007666180328142953
Mechanistic Description of Natural Herbs in the Treatment of Dementia: A Systematic Review
, 2018; 7(2): 149 - 164Bapi Gorain*, Hira Choudhury, Manisha Pandey, Hasbi Laili Bt Mohd Zaki, Nuurul Izzati Bt Bakar, Nur Hanis Bt Hamdhan, Nor Aniza Bt Musa, Nurul Fadhilah Bt Mustafa, Jaya Sree Sangkari, Nur Ain Athirah Bt Azmi, Lui Park Yeang and Prashant Kesharwani
DOI: 10.2174/2211556007666180420124544
Management of Adverse Effects from Atypical Antipsychotics
, 2018; 7(1): 23 - 35Ahsan Nazeer* and Joseph L. Calles
DOI: 10.2174/2211556007666180220162945
Meta-analysis of Native Studies as Regards the Effectiveness of Antidepressants on Deficit Syndrome of Schizophrenia: A Systematic Review
, 2017; 6(2): 148 - 157Saeed S. Shafti*
DOI: 10.2174/2211556006666170419161746
Psychiatric Polypharmacy, Etiology and Potential Consequences
, 2017; 6(1): 12 - 26Sonali Sarkar*
DOI: 10.2174/2211556005666160916124719
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96 - 138Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
A Comparison Between Quetiapine and Aripiprazole for Treatment of Schizophrenia: A Double Blind Contrast
, 2016; 5(1): 13 - 19Saeed S. Shafti and Hamid Kaviani
DOI: 10.2174/2211556005666160301231207
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
, 2015; 4(2): 96 - 102Claudia Becerra-Palars, Javier Amado-Lerma, Alejandra Andrade, Rafael Campuzano and Emilio Montemayor
DOI: 10.2174/2211556005666151216225423
Decreased Incidence of Readmissions in First Episode Psychosis in Treatment with Long - Acting Injectable Antipsychotics
, 2015; 4(1): 52 - 57Alba T. Privat, Daniel B. Baquero, Anna M. Santacana and Victor P. Sola
DOI: 10.2174/2211556004666150918194108
Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder
, 2014; 3(3): 219 - 225Saeed Shoja Shafti
DOI: 10.2174/221155600303150629162749
Open Access Articles
Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
, 2019; 8(1): 55 - 63Muhammad Akmal Yazdani, Muhammad Jamir Anwar, Bushra Parveen and Divya Vohora*
Protein Chimera-based Ca2+ Rewiring as a Treatment Modality for Neurodegeneration
, 2019; 8(1): 27 - 40Netra Unni Rajesh and Anam Qudrat*
Low-Dose Lithium for Long-Term Treatment of Clozapine- Induced Neutropenia: A Case Series
, 2019; 8: 1 - 4 (E-Pub Ahead of Print)Muhammad R. Baig*
Systematic Review of Local Studies Regarding Efficiency of Add-On Medications on Negative Symptoms of Schizophrenia: A Meta-Analysis
, 2019; 8: 1 - 10 (E-Pub Ahead of Print)Saeed Shoja Shafti*
Neurosteroids and Affective Disorders in Women
, 2019; 8: 1 - 11 (E-Pub Ahead of Print)Rodrigo Guiza Zayas *, Mónica Flores Ramos , Norma Bernal Santamaría , María Fernanda Del-Pino Mijares and Marián Serna-García
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96 - 138Caio Maximino, Bruna P. Costa and Monica G. Lima
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
, 2015; 4(2): 96 - 102Claudia Becerra-Palars, Javier Amado-Lerma, Alejandra Andrade, Rafael Campuzano and Emilio Montemayor
Most Cited Articles
Pharmacological Manipulation of Shoaling Behavior in Zebrafish
, 2016; 5(2): 180-193.Soaleha Shams and Robert T. Gerlai
DOI: 10.2174/2211556005666160607094906
Odyssey of ‘Negative Symptoms’ of Schizophrenia: Rehabilitation vs Stigmatization
, 2015; 4(1): 40-51.Saeed Shoja Shafti
DOI: 10.2174/2211556004666150918193742
The Novel Tank Test: Handling Stress and the Context Specific Psychopharmacology of Anxiety
, 2016; 5(2): 169-179.Steven Tran and Robert T. Gerlai
DOI: 10.2174/2211556005666160519144414
Relevance of Test- and Subject-Related Factors on Inhibitory Avoidance (Performance) of Zebrafish for Psychopharmacology Studies
, 2016; 5(2): 152-168.Remy Manuel, Marnix Gorissen and Ruud van den Bos
DOI: 10.2174/2211556005666160526111427
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96-138.Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
Zebrafish as an Animal Model to Study Epileptic Seizures and Epileptic Syndromes
, 2016; 5(2): 194-210.Ben H.M. Mussulini, Suelen Baggio, Luana Moro, Renato D. Dias, Maria E. Calcagnotto, Eduardo P. Rico and Diogo L. de Oliveira
DOI: 10.2174/2211556005666160615090734
Zebrafish Models to Study Fear and Anxiety
, 2016; 5(2): 139-151.Adam D. Collier and David J. Echevarria
DOI: 10.2174/2211556005666160608124610
Most Accessed Articles
The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
, 2019; 8(1): 5-26.Murray Johns*
DOI: 10.2174/2211556007666180503170231
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
, 2019; 8(1): 41-54.Andreea L. Seritan*, Peter Ureste, Tammy Duong and Jill L. Ostrem
DOI: 10.2174/2211556007666180328142953
Substance Use Disorder Related to Kratom (Mitragyna speciosa) Use in Malaysia
, 2019; 8(1): 64-71.Darshan Singh, Mohammad F.I.L. Abdullah, Balasingam K. Vicknasingam and Christian P. Müller*
DOI: 10.2174/2405461503666180420120649
Neurobehavioral Effects of β-Escin
, 2019; 8(1): 79-86.Huda J. Waheed, Saad B. Nashtar, Ali I. Al-Gareeb and Hayder M. Al-Kuraishy*
DOI: 10.2174/2211556007666180523103828
Systemic Injections of Primidone Cause Wake-Inducing Effects in Rats
, 2019; 8(1): 72-78.Mireille Salas-Crisóstomo, María J. Franco-Tormo, Niurka Trujillo-Paredes, Gloria Arankowsky-Sandoval, Óscar Arias-Carrión, Sérgio Machado and Eric Murillo-Rodríguez*
DOI: 10.2174/2211556007666180425143506
Protein Chimera-based Ca2+ Rewiring as a Treatment Modality for Neurodegeneration
, 2019; 8(1): 27-40.Netra Unni Rajesh and Anam Qudrat*
DOI: 10.2174/2211556007666181001102702
Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
, 2019; 8(1): 55-63.Muhammad Akmal Yazdani, Muhammad Jamir Anwar, Bushra Parveen and Divya Vohora*
DOI: 10.2174/2211556007666180705130103
Dietary Interventions for Diabetic Neuropathy & Nephropathy: A Review
, 2018; 7(2): 107-112.Onkar Bedi, Gagandeep Kaur, Harjeet Singh and Pawan Krishan*
DOI: 10.2174/2211556007666180420142729
  |
Editor-in-Chief
Silvio Bellino
Centre for Personality Disorders, Unit of Psychiatry 1
Department of Neuroscience
University of Turin
Turin
Italy
Biography
View Full Editorial Board
Centre for Personality Disorders, Unit of Psychiatry 1
Department of Neuroscience
University of Turin
Turin
Italy
Biography
Biography of Silvio Bellino
Silvio Bellino was born in Turin, Italy, on 27 April 1965. He graduated at the
University of Turin in 1990/91 and specialized in Psychiatry in 1995/96.
He became Researcher of Psychiatry at the Department of Neuroscience in
October 2001 and was charged of the Centre for Personality Disorders in
January 2007. He is Associate Professor of Psychiatry from July 2015.
He teaches psychiatry at the School of Medicine and at Schools of Medical
Specialization of the University of Turin.
His studies were focused on clinics and pharmacotherapy of personality
disorders, mood and anxiety disorders, and on interpersonal psychotherapy of
major depression and personality disorders.
He presented the results in Italian and international congresses and published
many articles in Italian and international indexed journals. He is Editor in Chief
of Current Psychopharmacology since 2011.
In December 2012 he became President of the Italian Society of Interpersonal
Psychotherapy.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Psychopharmacology was launched in 2012. Dr. Silvio Bellino serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net